JPMorgan Chase & Co. news

   Watch this stock
Showing stories 1 - 10 of about 178   

Articles published

JPM 59.17 +0.17 (0.29%)
price chart
Small Business, Big Investment: JPMorgan Chase & Co. Announces $30 Million ...
WASHINGTON, Jul 22, 2014 (BUSINESS WIRE) -- JPMorgan Chase & Co. today launched Small Business Forward SM, a five-year, $30 million grant program to boost small business support networks that help growing enterprises in specific industries.
Related articles »  
Lear Stock Rating Reaffirmed by JPMorgan Chase & Co. (LEA)
Lear Co. logo Lear (NYSE:LEA)'s stock had its �hold� rating reaffirmed by equities researchers at JPMorgan Chase & Co. in a research report issued on Tuesday. They currently have a $105.00 price target on the stock, up from their previous price target ...
Why JPMorgan Chase (JPM) Stock Is Gaining Today  TheStreet.com
Apache Stock Rating Reaffirmed by JPMorgan Chase & Co. (APA)  Mideast Time
Related articles »  
General Dynamics Given �Overweight� Rating at JPMorgan Chase & Co. (GD)
General Dynamics Co. logo General Dynamics (NYSE:GD)'s stock had its �overweight� rating restated by investment analysts at JPMorgan Chase & Co. in a note issued to investors on Thursday. They currently have a $130.00 price objective on the stock, ...
Related articles »  
Halliburton Company Price Target Raised to $78.50 at JPMorgan Chase & Co ...
Halliburton Company (NYSE:HAL) had its price objective hosited by JPMorgan Chase & Co. from $78.00 to $78.50 in a report released on Tuesday.
Halliburton Company PT Raised to $78.50 at JPMorgan Chase & Co. (HAL)  Watch List News (press release)
Related articles »  
Intuitive Surgical Given �Overweight� Rating at JPMorgan Chase & Co. (ISRG)
Intuitive Surgical, Inc. logo JPMorgan Chase & Co. restated their overweight rating on shares of Intuitive Surgical (NASDAQ:ISRG) in a report released on Wednesday.
Zacks Reiterates Neutral Rating for Intuitive Surgical (ISRG)  Mideast Time
Related articles »  
Gilead Sciences Receives �Overweight� Rating from JPMorgan Chase & Co ...
Gilead Sciences (NASDAQ:GILD)'s stock had its �overweight� rating restated by equities research analysts at JPMorgan Chase & Co. in a research note issued to investors on Thursday. They currently have a $110.00 target price on the stock, up from their ...
Related articles »  
BancorpSouth's Underweight Rating Reaffirmed at JPMorgan Chase & Co. (BXS)
BancorpSouth, Inc. logo BancorpSouth (NYSE:BXS)'s stock had its �underweight� rating reiterated by JPMorgan Chase & Co. in a research note issued on Wednesday. They currently have a $22.00 target price on the stock, down from their previous target ...
Related articles »  
Lennox International Stock Rating Reaffirmed by JPMorgan Chase & Co. (LII)
Lennox International Inc. logo Lennox International (NYSE:LII)'s stock had its �overweight� rating restated by analysts at JPMorgan Chase & Co. in a research report issued to clients and investors on Tuesday. They currently have a $97.00 price ...
Lennox International Upgraded to Buy at Goldman Sachs (LII)  Watch List News (press release)
Related articles »  
Why JPMorgan Chase & Co. Shares Could Pop 20%
While Fools should generally take the opinion of Wall Street with a grain of salt, it's not a bad idea to take a closer look at particularly stock-shaking upgrades and downgrades -- just in case their reasoning behind the call makes sense.
AT&T Receives Neutral Rating from JPMorgan Chase & Co. (T)
AT&T Inc. logo AT&T (NYSE:T)'s stock had its �neutral� rating restated by stock analysts at JPMorgan Chase & Co. in a report issued on Thursday. They currently have a $35.00 price target on the stock, up from their previous price target of $34.00 ...